Gastrointestinal Stents Market Is Projected To Grow Rapidly Due To Rising Burden Of Biliary Diseases, Esophageal Cancer, And Colorectal Cancer Till 2025: Grand View Research, Inc.
The global gastrointestinal stents (GI stents) market is expected
to reach USD 472.5 million by 2025, according to a new report by Grand View
Research, Inc. Increasing burden of gastrointestinal diseases including biliary
diseases, esophageal cancer, and colorectal cancer are anticipated to boost the
usage of GI stents across the globe.
Individuals above 60 years of age
form the key target population for these products, as they are at a high risk
of developing gastrointestinal and stomach-related diseases. Thus, aging
demographics of most of the economies around the globe is a prime factor
driving the growth of the sector. Moreover, reimbursement coverage provided by
the Center for Medicare & Medicaid Services (CMS) and various private
payers is spurring the adoption of GI stents.
U.S. gastrointestinal stents market revenue, by product,
2014 - 2025 (USD Million)
Browse full research
report on Gastrointestinal Stents Market: http://www.grandviewresearch.com/industry-analysis/gastrointestinal-gi-stents-market
Further key findings from the report suggest:
- The market study suggests that biliary stent
dominated the overall sector in 2016. Incidences of biliary diseases such
as bile duct cancer, gallstone disease and primary biliary cholangitis are
on the rise globally, which would drive the growth of biliary stents
sector positively.
- Esophageal stent segment is expected to witness
highest growth rate, owing to development of self-expanding plastic stents
and self-expanding metal stents, which have proved to be safe and
cost-effective for esophageal pathologies.
- Approximately, 50 % to 75 % of patients who are
primarily treated with endoscopic balloon dilation experience recurrence
of the structure within 1 year. Such patients are treated with
self-expanding metal stents, thereby driving the growth of the market
segment.
- North America occupied the largest revenue share in
2016, due to the high rate of diagnosing new cases of gastrointestinal
diseases and constantly rising awareness regarding commercial availability
of effective treatments.
- In addition, increasing incidences of irritable
bowel syndrome, colorectal cancer and pancreatic cancer are a few high
impact-rendering drivers for the market
- Asia Pacific is expected to witness a significant
growth during the forecast period. The presence of countries such as
Japan, China and India with constantly increasing patient population is a
key factor anticipated to fuel the market growth in the region.
- Some of the major companies operating in this market
are Boston Scientific, Cook Medical, ELLA-CS, s.r.o., ConMed, Gore
Medical, TaeWoong Medical, Hobbs Medical, Inc., C.R. Bard, Merit Endotek,
Olympus America and others.
Access Press
Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-gastrointestinal-gi-stents-market
About Grand View Research,
Inc:
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
For more information: http://www.grandviewresearch.com
Comments
Post a Comment